
=== FINAL SUMMARY ===

**One-sentence overview:** The company's stock-related activities from 2016 to 2019 show significant changes in shares outstanding, exercise prices, and contractual terms, with notable anomalies in 2019.

1. The number of shares outstanding decreased from 3015374 in 2016 to 1686902 in 2019.
2. The weighted-average exercise price per share increased from $3.95 in 2016 to $7.00 in 2019.
3. A significant number of shares were exercised in 2019 (1384647), much higher than in previous years.
4. The weighted-average remaining contractual term decreased from 6.4 years in 2016 to 4.6 years in 2018, then increased to 5.4 years in 2019.
5. The exercise price for granted shares increased each year: $7.06 in 2016, $8.60 in 2017, and $9.59 in 2018.
6. The number of shares canceled in 2019 (144183) was higher than in previous years.

Answer Echoes:
- "The Company recognized $0.7 million, $1.4 million, and $1.0 million in stock-based compensation expense related to outstanding stock options in the fiscal years ended September 30, 2019, 2018, and 2017, respectively."
- "As of September 30, 2019, the Company had $2.0 million of unrecognized compensation expense related to outstanding stock options expected to be recognized over a weighted-average period of approximately three years."
- "The total intrinsic value of options exercised during the fiscal years ended September 30, 2019, 2018, and 2017 was $11.1 million, $1.4 million, and $1.4 million, respectively."
- "The per-share weighted-average fair value of options granted during the fiscal years ended September 30, 2019, 2018, and 2017 was $5.07, $4.56, and $4.28, respectively."
- "The aggregate intrinsic value of options outstanding as of September 30, 2019 and 2018, was $4.9 million and $8.7 million, respectively."
- "The number of shares outstanding decreased from 3,015,374 in 2016 to 1,686,902 in 2019."
- "The weighted-average exercise price per share increased from $3.95 in 2016 to $7.00 in 2019."
- "A significant number of shares were exercised in 2019 (1,384,647), much higher than in previous years."
- "The weighted-average remaining contractual term decreased from 6.4 years in 2016 to 4.6 years in 2018, then increased to 5.4 years in 2019."
- "The exercise price for granted shares increased each year: $7.06 in 2016, $8.60 in 2017, and $9.59 in 2018."
- "The number of shares canceled in 2019 (144,183) was higher than in previous years."

=== LOGS (per-agent) ===
{'TabuSynth': {'cot': '1. Note the number of shares outstanding at each '
                      'year-end: 2016, 2017, 2018, and 2019.\n'
                      '2. Calculate the change in the number of shares '
                      'outstanding from 2016 to 2019.\n'
                      '3. Observe the weighted-average exercise price per '
                      'share for each year.\n'
                      '4. Identify any significant changes in the exercise '
                      'price over the years.\n'
                      '5. Note the weighted-average remaining contractual term '
                      'for each year.\n'
                      '6. Identify any trends or anomalies in the contractual '
                      'term over the years.',
               'result': '[TREND] The number of shares outstanding decreased '
                         'from 3,015,374 in 2016 to 1,686,902 in 2019.\n'
                         '[TREND] The weighted-average exercise price per '
                         'share increased from $3.95 in 2016 to $7.00 in '
                         '2019.\n'
                         '[ANOMALY] A significant number of shares were '
                         'exercised in 2019 (1,384,647), much higher than in '
                         'previous years.\n'
                         '[TREND] The weighted-average remaining contractual '
                         'term decreased from 6.4 years in 2016 to 4.6 years '
                         'in 2018, then increased to 5.4 years in 2019.\n'
                         '[RATIO] The exercise price for granted shares '
                         'increased each year: $7.06 in 2016, $8.60 in 2017, '
                         'and $9.59 in 2018.\n'
                         '[OUTLIER] The number of shares canceled in 2019 '
                         '(144,183) was higher than in previous years.',
               'raw': '{\n'
                      '  "reasoning": "1. Note the number of shares '
                      'outstanding at each year-end: 2016, 2017, 2018, and '
                      '2019.\\n2. Calculate the change in the number of shares '
                      'outstanding from 2016 to 2019.\\n3. Observe the '
                      'weighted-average exercise price per share for each '
                      'year.\\n4. Identify any significant changes in the '
                      'exercise price over the years.\\n5. Note the '
                      'weighted-average remaining contractual term for each '
                      'year.\\n6. Identify any trends or anomalies in the '
                      'contractual term over the years.",\n'
                      '  "bullets": [\n'
                      '    "[TREND] The number of shares outstanding decreased '
                      'from 3,015,374 in 2016 to 1,686,902 in 2019.",\n'
                      '    "[TREND] The weighted-average exercise price per '
                      'share increased from $3.95 in 2016 to $7.00 in 2019.",\n'
                      '    "[ANOMALY] A significant number of shares were '
                      'exercised in 2019 (1,384,647), much higher than in '
                      'previous years.",\n'
                      '    "[TREND] The weighted-average remaining contractual '
                      'term decreased from 6.4 years in 2016 to 4.6 years in '
                      '2018, then increased to 5.4 years in 2019.",\n'
                      '    "[RATIO] The exercise price for granted shares '
                      'increased each year: $7.06 in 2016, $8.60 in 2017, and '
                      '$9.59 in 2018.",\n'
                      '    "[OUTLIER] The number of shares canceled in 2019 '
                      '(144,183) was higher than in previous years."\n'
                      '  ]\n'
                      '}'},
 'Contextron': {'cot': 'The TABLE CONTEXT provides trends and anomalies '
                       'related to stock options, such as changes in shares '
                       'outstanding, exercise prices, and contractual terms. '
                       'However, it lacks specific figures for stock-based '
                       'compensation expenses and intrinsic values, which are '
                       'provided in the CONTEXT. The CONTEXT details '
                       'stock-based compensation expenses for fiscal years '
                       '2017, 2018, and 2019, as well as intrinsic values for '
                       'options exercised and outstanding. By combining data '
                       'from both contexts, we can address the questions '
                       'comprehensively, ensuring all relevant figures and '
                       'trends are included.',
                'result': '- "The Company recognized $0.7 million, $1.4 '
                          'million, and $1.0 million in stock-based '
                          'compensation expense related to outstanding stock '
                          'options in the fiscal years ended September 30, '
                          '2019, 2018, and 2017, respectively."\n'
                          '- "As of September 30, 2019, the Company had $2.0 '
                          'million of unrecognized compensation expense '
                          'related to outstanding stock options expected to be '
                          'recognized over a weighted-average period of '
                          'approximately three years."\n'
                          '- "The total intrinsic value of options exercised '
                          'during the fiscal years ended September 30, 2019, '
                          '2018, and 2017 was $11.1 million, $1.4 million, and '
                          '$1.4 million, respectively."\n'
                          '- "The per-share weighted-average fair value of '
                          'options granted during the fiscal years ended '
                          'September 30, 2019, 2018, and 2017 was $5.07, '
                          '$4.56, and $4.28, respectively."\n'
                          '- "The aggregate intrinsic value of options '
                          'outstanding as of September 30, 2019 and 2018, was '
                          '$4.9 million and $8.7 million, respectively."\n'
                          '- "The number of shares outstanding decreased from '
                          '3,015,374 in 2016 to 1,686,902 in 2019."\n'
                          '- "The weighted-average exercise price per share '
                          'increased from $3.95 in 2016 to $7.00 in 2019."\n'
                          '- "A significant number of shares were exercised in '
                          '2019 (1,384,647), much higher than in previous '
                          'years."\n'
                          '- "The weighted-average remaining contractual term '
                          'decreased from 6.4 years in 2016 to 4.6 years in '
                          '2018, then increased to 5.4 years in 2019."\n'
                          '- "The exercise price for granted shares increased '
                          'each year: $7.06 in 2016, $8.60 in 2017, and $9.59 '
                          'in 2018."\n'
                          '- "The number of shares canceled in 2019 (144,183) '
                          'was higher than in previous years."',
                'raw': 'The TABLE CONTEXT provides trends and anomalies '
                       'related to stock options, such as changes in shares '
                       'outstanding, exercise prices, and contractual terms. '
                       'However, it lacks specific figures for stock-based '
                       'compensation expenses and intrinsic values, which are '
                       'provided in the CONTEXT. The CONTEXT details '
                       'stock-based compensation expenses for fiscal years '
                       '2017, 2018, and 2019, as well as intrinsic values for '
                       'options exercised and outstanding. By combining data '
                       'from both contexts, we can address the questions '
                       'comprehensively, ensuring all relevant figures and '
                       'trends are included.\n'
                       '\n'
                       '- "The Company recognized $0.7 million, $1.4 million, '
                       'and $1.0 million in stock-based compensation expense '
                       'related to outstanding stock options in the fiscal '
                       'years ended September 30, 2019, 2018, and 2017, '
                       'respectively."\n'
                       '- "As of September 30, 2019, the Company had $2.0 '
                       'million of unrecognized compensation expense related '
                       'to outstanding stock options expected to be recognized '
                       'over a weighted-average period of approximately three '
                       'years."\n'
                       '- "The total intrinsic value of options exercised '
                       'during the fiscal years ended September 30, 2019, '
                       '2018, and 2017 was $11.1 million, $1.4 million, and '
                       '$1.4 million, respectively."\n'
                       '- "The per-share weighted-average fair value of '
                       'options granted during the fiscal years ended '
                       'September 30, 2019, 2018, and 2017 was $5.07, $4.56, '
                       'and $4.28, respectively."\n'
                       '- "The aggregate intrinsic value of options '
                       'outstanding as of September 30, 2019 and 2018, was '
                       '$4.9 million and $8.7 million, respectively."\n'
                       '- "The number of shares outstanding decreased from '
                       '3,015,374 in 2016 to 1,686,902 in 2019."\n'
                       '- "The weighted-average exercise price per share '
                       'increased from $3.95 in 2016 to $7.00 in 2019."\n'
                       '- "A significant number of shares were exercised in '
                       '2019 (1,384,647), much higher than in previous '
                       'years."\n'
                       '- "The weighted-average remaining contractual term '
                       'decreased from 6.4 years in 2016 to 4.6 years in 2018, '
                       'then increased to 5.4 years in 2019."\n'
                       '- "The exercise price for granted shares increased '
                       'each year: $7.06 in 2016, $8.60 in 2017, and $9.59 in '
                       '2018."\n'
                       '- "The number of shares canceled in 2019 (144,183) was '
                       'higher than in previous years."'},
 'SummaCraft': {'cot': '(omitted)',
                'result': "**One-sentence overview:** The company's "
                          'stock-related activities from 2016 to 2019 show '
                          'significant changes in shares outstanding, exercise '
                          'prices, and contractual terms, with notable '
                          'anomalies in 2019.\n'
                          '\n'
                          '1. The number of shares outstanding decreased from '
                          '3015374 in 2016 to 1686902 in 2019.\n'
                          '2. The weighted-average exercise price per share '
                          'increased from $3.95 in 2016 to $7.00 in 2019.\n'
                          '3. A significant number of shares were exercised in '
                          '2019 (1384647), much higher than in previous '
                          'years.\n'
                          '4. The weighted-average remaining contractual term '
                          'decreased from 6.4 years in 2016 to 4.6 years in '
                          '2018, then increased to 5.4 years in 2019.\n'
                          '5. The exercise price for granted shares increased '
                          'each year: $7.06 in 2016, $8.60 in 2017, and $9.59 '
                          'in 2018.\n'
                          '6. The number of shares canceled in 2019 (144183) '
                          'was higher than in previous years.\n'
                          '\n'
                          'Answer Echoes:\n'
                          '- "The Company recognized $0.7 million, $1.4 '
                          'million, and $1.0 million in stock-based '
                          'compensation expense related to outstanding stock '
                          'options in the fiscal years ended September 30, '
                          '2019, 2018, and 2017, respectively."\n'
                          '- "As of September 30, 2019, the Company had $2.0 '
                          'million of unrecognized compensation expense '
                          'related to outstanding stock options expected to be '
                          'recognized over a weighted-average period of '
                          'approximately three years."\n'
                          '- "The total intrinsic value of options exercised '
                          'during the fiscal years ended September 30, 2019, '
                          '2018, and 2017 was $11.1 million, $1.4 million, and '
                          '$1.4 million, respectively."\n'
                          '- "The per-share weighted-average fair value of '
                          'options granted during the fiscal years ended '
                          'September 30, 2019, 2018, and 2017 was $5.07, '
                          '$4.56, and $4.28, respectively."\n'
                          '- "The aggregate intrinsic value of options '
                          'outstanding as of September 30, 2019 and 2018, was '
                          '$4.9 million and $8.7 million, respectively."\n'
                          '- "The number of shares outstanding decreased from '
                          '3,015,374 in 2016 to 1,686,902 in 2019."\n'
                          '- "The weighted-average exercise price per share '
                          'increased from $3.95 in 2016 to $7.00 in 2019."\n'
                          '- "A significant number of shares were exercised in '
                          '2019 (1,384,647), much higher than in previous '
                          'years."\n'
                          '- "The weighted-average remaining contractual term '
                          'decreased from 6.4 years in 2016 to 4.6 years in '
                          '2018, then increased to 5.4 years in 2019."\n'
                          '- "The exercise price for granted shares increased '
                          'each year: $7.06 in 2016, $8.60 in 2017, and $9.59 '
                          'in 2018."\n'
                          '- "The number of shares canceled in 2019 (144,183) '
                          'was higher than in previous years."',
                'raw': "**One-sentence overview:** The company's stock-related "
                       'activities from 2016 to 2019 show significant changes '
                       'in shares outstanding, exercise prices, and '
                       'contractual terms, with notable anomalies in 2019.\n'
                       '\n'
                       '1. The number of shares outstanding decreased from '
                       '3,015,374 in 2016 to 1,686,902 in 2019.\n'
                       '2. The weighted-average exercise price per share '
                       'increased from $3.95 in 2016 to $7.00 in 2019.\n'
                       '3. A significant number of shares were exercised in '
                       '2019 (1,384,647), much higher than in previous years.\n'
                       '4. The weighted-average remaining contractual term '
                       'decreased from 6.4 years in 2016 to 4.6 years in 2018, '
                       'then increased to 5.4 years in 2019.\n'
                       '5. The exercise price for granted shares increased '
                       'each year: $7.06 in 2016, $8.60 in 2017, and $9.59 in '
                       '2018.\n'
                       '6. The number of shares canceled in 2019 (144,183) was '
                       'higher than in previous years.'}}
